PL2821415T3 - Przeciwciało przeciwko lipoarabinomannanowi i test immunologiczny do oznaczania zakażenia kwasoopornymi prątkami przy użyciu tego przeciwciała - Google Patents

Przeciwciało przeciwko lipoarabinomannanowi i test immunologiczny do oznaczania zakażenia kwasoopornymi prątkami przy użyciu tego przeciwciała

Info

Publication number
PL2821415T3
PL2821415T3 PL13755814T PL13755814T PL2821415T3 PL 2821415 T3 PL2821415 T3 PL 2821415T3 PL 13755814 T PL13755814 T PL 13755814T PL 13755814 T PL13755814 T PL 13755814T PL 2821415 T3 PL2821415 T3 PL 2821415T3
Authority
PL
Poland
Prior art keywords
antibody
immunoassay
acid
lipoarabinomannan
fast bacillary
Prior art date
Application number
PL13755814T
Other languages
English (en)
Inventor
Kiyonori Katsuragi
Masataka Togashi
Tetsuya Oda
Ryuta Ito
Chie KAWAGUCHI
Yoko Saijo
Daisuke Koga
Makoto Matsumoto
Mamoru Fujiwara
Kenji Ono
Original Assignee
Otsuka Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co., Ltd. filed Critical Otsuka Pharmaceutical Co., Ltd.
Publication of PL2821415T3 publication Critical patent/PL2821415T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267Gram-positive bacteria
    • C07K16/1285Gram-positive bacteria from Corynebacterium (G)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/5695Mycobacteria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/005Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267Gram-positive bacteria
    • C07K16/1289Mycobacteriaceae (F)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203Gram-negative bacteria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/35Valency
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/60Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622Single chain antibody (scFv)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/35Assays involving biological materials from specific organisms or of a specific nature from bacteria from Mycobacteriaceae (F)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/50Lipopolysaccharides; LPS
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PL13755814T 2012-02-29 2013-02-28 Przeciwciało przeciwko lipoarabinomannanowi i test immunologiczny do oznaczania zakażenia kwasoopornymi prątkami przy użyciu tego przeciwciała PL2821415T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012044796 2012-02-29
EP13755814.4A EP2821415B1 (en) 2012-02-29 2013-02-28 Anti-lipoarabinomannan antibody and immunoassay for acid-fast bacillary infection using the antibody
PCT/JP2013/055591 WO2013129634A1 (ja) 2012-02-29 2013-02-28 抗リポアラビノマンナン抗体及び当該抗体を用いた抗酸菌症のイムノアッセイ

Publications (1)

Publication Number Publication Date
PL2821415T3 true PL2821415T3 (pl) 2021-07-05

Family

ID=49082822

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13755814T PL2821415T3 (pl) 2012-02-29 2013-02-28 Przeciwciało przeciwko lipoarabinomannanowi i test immunologiczny do oznaczania zakażenia kwasoopornymi prątkami przy użyciu tego przeciwciała

Country Status (13)

Country Link
US (1) US9512206B2 (pl)
EP (1) EP2821415B1 (pl)
JP (3) JP6410601B2 (pl)
KR (1) KR101707291B1 (pl)
CN (1) CN104144944B (pl)
AU (1) AU2013205658B2 (pl)
CA (1) CA2865496C (pl)
DK (1) DK2821415T3 (pl)
ES (1) ES2865023T3 (pl)
PH (1) PH12014501783B1 (pl)
PL (1) PL2821415T3 (pl)
TW (1) TWI555756B (pl)
WO (1) WO2013129634A1 (pl)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6693134B2 (ja) * 2015-02-02 2020-05-13 東ソー株式会社 リンカー配列を有する抗体及びそれを用いた測定法
RU2732502C2 (ru) 2016-02-10 2020-09-18 Ратгерс, Де Стейт Юниверсити Оф Нью Джерси Новые моноклональные антитела к LAM и PIM6/LAM для диагностики и лечения инфекций, вызванных Mycobacterium tuberculosis
WO2017156910A1 (zh) * 2016-03-14 2017-09-21 北京康华源科技发展有限公司 一种离心分离检测方法及装置
WO2017204349A1 (en) * 2016-05-27 2017-11-30 Otsuka Pharmaceutical Co., Ltd. Methods and assays for estimating acid-fast bacteria viability, and kits therefor
US10837962B2 (en) 2017-12-20 2020-11-17 General Electric Company Method and associated device for rapid detection of target biomolecules with enhanced sensitivity
KR20190076897A (ko) * 2017-12-22 2019-07-02 주식회사 수젠텍 결핵 진단 방법
CN112005117A (zh) * 2018-03-29 2020-11-27 创新诊断基金会 抗体或抗体组合以及使用其检测受试者尿液样品中与分枝杆菌相关的抗原的方法
US11643455B2 (en) 2018-04-13 2023-05-09 Albert Einstein College Of Medicine High-affinity Mycobacterium tuberculosis capsule-specific human monoclonal antibody
WO2019200255A1 (en) * 2018-04-13 2019-10-17 Albert Einstein College Of Medicine High-affinity mycobacterium tuberculosis capsule-specific human monoclonal antibody
CN112639472A (zh) 2018-08-31 2021-04-09 富士胶片株式会社 免疫层析试剂盒及结核菌的检测方法
CN112805299B (zh) 2018-10-05 2025-09-16 西雅图儿童医院以西雅图儿童研究机构名义经营 针对原发性免疫缺陷、胱氨酸病和威尔逊病的新生儿筛查
CN110568185B (zh) * 2019-08-06 2022-11-18 上海荣盛生物药业股份有限公司 脂阿拉伯甘露聚糖检测助剂及其组合物和试剂盒
CN110568186B (zh) * 2019-08-06 2022-12-16 上海荣盛生物药业股份有限公司 检测脂阿拉伯甘露聚糖的组分及其试剂盒
WO2021065144A1 (ja) * 2019-09-30 2021-04-08 富士フイルム株式会社 イムノクロマトグラフィー
WO2021065300A1 (ja) 2019-09-30 2021-04-08 富士フイルム株式会社 免疫検査方法及び濃縮用治具
CN113087789B (zh) * 2019-12-23 2022-09-23 中国农业大学 丝状噬菌体pⅧ蛋白单克隆抗体及其应用
CN111337665A (zh) * 2020-01-16 2020-06-26 卢氏实验室公司 一种用于检测肺结核感染的免疫层析试纸条及其制备方法
JP7257556B2 (ja) 2020-01-31 2023-04-13 富士フイルム株式会社 イムノクロマトグラフィー
EP4099016A4 (en) 2020-01-31 2023-02-15 FUJIFILM Corporation IMMUNOCHROMATOGRAPHY
JP7740995B2 (ja) 2020-01-31 2025-09-17 富士フイルム株式会社 免疫検査方法
CN111153992A (zh) * 2020-02-21 2020-05-15 首都医科大学附属北京胸科医院 结核分枝杆菌lam的单克隆抗体及其用途
US11940448B2 (en) 2020-03-31 2024-03-26 Seattle Children's Hospital Proteomic screening for lysosomal storage diseases
US12523662B2 (en) 2020-04-02 2026-01-13 Seattle Children's Hospital Antibodies that specifically bind peptides associated with the primary immunodeficiencies: Wiskott-Aldrich syndrome and x-linked agammaglobulinemia
EP4212873A4 (en) 2020-09-11 2024-06-05 FUJIFILM Corporation CONCENTRATION DEVICE, METHOD FOR CONCENTRATING A SAMPLE SOLUTION, METHOD FOR TESTING A SAMPLE SOLUTION AND TEST KIT
JP7425883B2 (ja) 2020-09-11 2024-01-31 富士フイルム株式会社 濃縮デバイス、検体液の濃縮方法、検体液の検査方法、及び、検査キット
JP7554275B2 (ja) 2020-09-11 2024-09-19 富士フイルム株式会社 検体液の濃縮方法、及び、検体液の検査方法
EP4263598A4 (en) * 2020-12-15 2025-04-09 Albert Einstein College of Medicine High-affinity mycobacterium tuberculosis capsule-specific human monoclonal antibodies
CN112940114B (zh) * 2021-02-09 2022-07-12 丹娜(天津)生物科技股份有限公司 一种抗真菌1,3-β-D-葡聚糖单克隆抗体及其应用
CN113480659B (zh) * 2021-06-30 2022-10-21 迪比康(上海)生物科技有限公司 人源抗结核分枝杆菌复合群lam单克隆抗体及其制备和应用
CN116381231B (zh) * 2023-04-06 2025-09-26 首都医科大学附属北京胸科医院 检测分枝杆菌脂阿拉伯甘露聚糖的抗体组合及其应用和试剂盒
CN117247450B (zh) * 2023-10-10 2025-02-25 广州市雷德生物科技有限公司 一种lam抗体及其应用
CN118063606B (zh) * 2024-04-24 2024-07-05 江西赛基生物技术有限公司 一种抗thsd7a单克隆抗体及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6545130B2 (en) 1997-06-04 2003-04-08 Albert Einstein College Of Medicine Of Yeshiva University Monoclonal antibodies to mycobacterium tuberculosis and a modified ELISA assay
CU23406A1 (es) 2002-11-25 2009-08-04 Inst Finlay Composiciones contienendo anticuerpos humanos para el tratamiento y profiláxis de infecciones por micobacterias
WO2005035753A1 (ja) 2003-10-10 2005-04-21 Chugai Seiyaku Kabushiki Kaisha 機能蛋白質を代替する二重特異性抗体
ES2540807T3 (es) * 2007-05-04 2015-07-13 Technophage, Investigação E Desenvolvimento Em Biotecnologia, Sa Dominios variables de anticuerpos de conejo modificados por ingeniería genética y usos de los mismos
CN101661044B (zh) * 2008-08-27 2013-10-16 复旦大学附属华山医院 一种结核病诊断试剂及试剂盒
CA2778401C (en) 2009-10-21 2019-08-13 Hiroshima University Integrin alpha 8-beta 1-specific monoclonal antibody
CN202083695U (zh) 2011-01-28 2011-12-21 上海科新生物技术股份有限公司 胶体金层析法抗核小体抗体检测试纸

Also Published As

Publication number Publication date
JP6410601B2 (ja) 2018-10-24
CA2865496A1 (en) 2013-09-06
US20160083458A1 (en) 2016-03-24
KR20140130699A (ko) 2014-11-11
PH12014501783A1 (en) 2014-11-10
US9512206B2 (en) 2016-12-06
RU2014138806A (ru) 2016-04-20
AU2013205658B2 (en) 2015-04-16
CN104144944A (zh) 2014-11-12
JPWO2013129634A1 (ja) 2015-07-30
ES2865023T3 (es) 2021-10-14
DK2821415T3 (da) 2021-04-26
AU2013205658A1 (en) 2013-09-19
EP2821415B1 (en) 2021-03-31
CA2865496C (en) 2019-09-03
JP6622363B2 (ja) 2019-12-18
CN104144944B (zh) 2016-06-29
JP2017218453A (ja) 2017-12-14
TWI555756B (zh) 2016-11-01
EP2821415A4 (en) 2015-09-30
WO2013129634A1 (ja) 2013-09-06
PH12014501783B1 (en) 2019-11-08
EP2821415A1 (en) 2015-01-07
TW201400500A (zh) 2014-01-01
JP2019014717A (ja) 2019-01-31
KR101707291B1 (ko) 2017-02-15

Similar Documents

Publication Publication Date Title
PL2821415T3 (pl) Przeciwciało przeciwko lipoarabinomannanowi i test immunologiczny do oznaczania zakażenia kwasoopornymi prątkami przy użyciu tego przeciwciała
ZA201502267B (en) Pyrrolobenzodiazepine-anti-her2 antibody conjugates
IL240438A0 (en) New antibody conjugates and their uses
AU2013355931A1 (en) Anti-folr1 antibody
HUE041274T2 (hu) Pirrolobenzodiazepin-anti-PSMA-antitest konjugátumok
SMT201800010T1 (it) Coniugati pirrolobenzodiazepina-anticorpo anti-cd22
LT2911699T (lt) Modifikuotas antikūnas, antikūnų konjugatas ir jų gavimo būdas
DK2912183T3 (da) Pr13.5-promotor til robuste t-celle- og antistofresponser
ZA201407316B (en) Anti-fgfr2 antibody
ZA201405554B (en) Anti-big-endothelin-1 (big-et-1) antibodies and uses thereof
ZA201407079B (en) Cdr-modified anti-siglec-15 antibody
ZA201504538B (en) Anti-lamp1 antibodies and antibody drug conjugates ,and uses thereof
PL2650310T3 (pl) Przeciwciało przeciw-ADAMTS-5, jego pochodne i zastosowania
GB201220242D0 (en) Antibody
IL238629A0 (en) Antibodies against prokinectin receptor and their uses
EP2811018A4 (en) ANTI-BODY ANTI-sAPPß
GB201208372D0 (en) Antibodies and uses thereof